KACY MCDONOUGH: Open Payments
NPI 1811579501 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 41 payments from 12 companies in 2025. Trend: 2023 $437 · 2024 $368 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $248 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Novo Nordisk Inc | 4 | $56 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Viatris Specialty LLC | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| Corcept Therapeutics | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, Wegovy, TRELEGY ELLIPTA, AIRSUPRA, QULIPTA, BREZTRI.
Industry payments across NC — which companies pay providers there.
